Sponsor Pipeline

Weijia Fang, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05862168 Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral… Oral Squamous Cell Carcinoma Recruiting
Phase 1
NCT05518253 A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive… Metastatic Tumor Recruiting
NCT06821048 Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant… Colorectal Cancer Recruiting
Early Phase 1
NCT07420010 An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability… Ovarian Cancer Not Yet Recruiting
Disease Areas
Ovarian Cancer (2) Colorectal Cancer (2) Kidney Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Mesothelioma (1)
Get alerts when Weijia Fang, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free